Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amarin
2
×
biotech
diabetes
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
vascepa
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amgen
aridis pharmaceuticals
aristea therapeutics
attack
autoimmune diseases
axitinib
bellus health
biotech ipos
bolt biotherapeutics
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
cardiovascular
cell therapy
cholesterol
cidara therapeutics
cigna
clinical trials
concert pharmaceuticals
What
abuzz
advantages
ago
amarin
bar
big
bio
brings
clinical
community
deeper
dive
doctors
drug
eager
expect
fish
gamble
gives
market
medco’s
medical
months
mover
new
oil
patients
payers
physicians
plan
ponder
prescription
pricing
reduce
risk
roundup
sets
showed
study
supplement
Language
unset
Current search:
amarin
×
diabetes
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Deeper Dive: Amarin Fish-Oil Study Gives Eager Doctors More to Ponder